NBIX in the 13F filings
Neurocrine Biosciences Inc · CUSIP 64125C109
- Quarter end
- 31 Mar 2025
- the date the book describes
- Filed
- 15 May 2025
- latest of these filings; the earliest 13 May 2025
- Managers listing it
- 14
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q4 2024 and Q1 2025; 10 listed it in both
- Shares listed
- 14,253,799
- combined, among listed positions
- Reported value
- $1.6bn
- combined, at the quarter end
Among the 95 comparable managers: 10 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing NBIX in Q1 2025
14 of 14 holders
Largest increases and reductions, by shares
Increases
- Dodge & Coxexisting position · 5,534,624 shares now+2,518,199
- Wellington Management Group LLPexisting position · 2,097,981 shares now+640,556
- Woodline Partners LPnew position · 132,892 shares now+132,892
- T. Rowe Price Associates Incexisting position · 1,539,601 shares now+49,088
- Soros Fund Management LLCexisting position · 239,823 shares now+39,823
Reductions
- AQR Capital Management LLCexisting position · 1,074,630 shares now-822,261
- Bridgewater Associates LPexisting position · 87,238 shares now-245,360
- PDT Partners LLCexisting position · 18,405 shares now-16,343
- Janus Henderson Group Ltdexisting position · 783,966 shares now-10,152
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 1 | $2.7m | n.a. | n.a. |
| Q3 2013 | 1 | $5.9m | n.a. | n.a. |
| Q4 2013 | 1 | $4.9m | n.a. | n.a. |
| Q1 2014 | 2 | $184m | n.a. | n.a. |
| Q2 2014 | 2 | $19m | n.a. | n.a. |
| Q3 2014 | 2 | $174m | n.a. | n.a. |
| Q4 2014 | 3 | $278m | n.a. | n.a. |
| Q1 2015 | 5 | $990m | n.a. | n.a. |
| Q2 2015 | 7 | $1.1bn | n.a. | n.a. |
| Q3 2015 | 7 | $975m | n.a. | n.a. |
| Q4 2015 | 8 | $1.6bn | n.a. | n.a. |
| Q1 2016 | 6 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 9 | $1.2bn | n.a. | n.a. |
| Q3 2016 | 11 | $1.5bn | n.a. | n.a. |
| Q4 2016 | 7 | $959m | n.a. | n.a. |
| Q1 2017 | 7 | $960m | n.a. | n.a. |
| Q2 2017 | 11 | $1.5bn | n.a. | n.a. |
| Q3 2017 | 13 | $2.2bn | n.a. | n.a. |
| Q4 2017 | 17 | $2.8bn | n.a. | n.a. |
| Q1 2018 | 13 | $3.0bn | n.a. | n.a. |
| Q2 2018 | 15 | $3.6bn | n.a. | n.a. |
| Q3 2018 | 20 | $4.3bn | n.a. | n.a. |
| Q4 2018 | 16 | $2.4bn | n.a. | n.a. |
| Q1 2019 | 18 | $2.6bn | n.a. | n.a. |
| Q2 2019 | 12 | $2.2bn | n.a. | n.a. |
| Q3 2019 | 12 | $2.4bn | n.a. | n.a. |
| Q4 2019 | 19 | $2.8bn | n.a. | n.a. |
| Q1 2020 | 13 | $2.2bn | n.a. | n.a. |
| Q2 2020 | 12 | $3.3bn | n.a. | n.a. |
| Q3 2020 | 15 | $2.6bn | n.a. | n.a. |
| Q4 2020 | 12 | $2.6bn | n.a. | n.a. |
| Q1 2021 | 6 | $2.3bn | n.a. | n.a. |
| Q2 2021 | 9 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 8 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 14 | $1.3bn | n.a. | n.a. |
| Q1 2022 | 15 | $1.4bn | n.a. | n.a. |
| Q2 2022 | 11 | $1.3bn | n.a. | n.a. |
| Q3 2022 | 14 | $1.0bn | n.a. | n.a. |
| Q4 2022 | 15 | $1.2bn | n.a. | n.a. |
| Q1 2023 | 17 | $860m | n.a. | n.a. |
| Q2 2023 | 16 | $1.1bn | n.a. | n.a. |
| Q3 2023 | 24 | $1.4bn | n.a. | n.a. |
| Q4 2023 | 21 | $1.6bn | 10 | 12 |
| Q1 2024 | 19 | $1.5bn | 9 | 11 |
| Q2 2024 | 17 | $1.4bn | 10 | 9 |
| Q3 2024 | 11 | $1.2bn | 7 | 5 |
| Q4 2024 | 14 | $2.0bn | 10 | 4 |
| Q1 2025 | 14 | $1.6bn | 10 | 4 |
| Q2 2025 | 16 | $2.5bn | 10 | 7 |
| Q3 2025 | 15 | $2.6bn | 7 | 8 |
| Q4 2025 | 21 | $2.8bn | 17 | 21 |
| Q1 2026 | 17 | $2.9bn | 16 | 19 |
| Q2 2026 | 10 | $2.7bn | 16 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
NBIX and GILD →NBIX and AMGN →NBIX and ARGX →Choose a stock to compare with NBIX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own NBIX, latest filings →Back to the 13F Explorer →